0001140361-14-042931.txt : 20141120 0001140361-14-042931.hdr.sgml : 20141120 20141120153201 ACCESSION NUMBER: 0001140361-14-042931 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141118 FILED AS OF DATE: 20141120 DATE AS OF CHANGE: 20141120 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HERLIHY WALTER C CENTRAL INDEX KEY: 0001241029 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 141238870 MAIL ADDRESS: STREET 1: C/O REPLIGEN CORP 41 STREET 2: SEYON ST. BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 doc1.xml FORM 4 X0306 4 2014-11-18 0 0000730272 REPLIGEN CORP RGEN 0001241029 HERLIHY WALTER C C/O REPLIGEN CORPORATION 41 SEYON ST, BLDG 1, STE 100 WALTHAM MA 02453 1 1 0 0 PRESIDENT, CEO Common Stock 2014-11-18 4 S 0 47228 23.47 D 500819 D Common Stock 2014-11-19 4 S 0 4158 22.95 D 496661 D $23.47 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.08 to $23.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $22.95 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.89 to $23.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. /s/ Jeffrey P. Leduc (Attorney in Fact) 2014-11-20